THC Therapeutics Files 8-K/A Amendment
| Field | Detail |
|---|---|
| Company | Thc Therapeutics, Inc. |
| Form Type | 8-K/A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing-update, corporate-governance
TL;DR
THC Therapeutics amended its 8-K filing to add a missing letter from Romanek.
AI Summary
THC Therapeutics, Inc. filed an 8-K/A amendment on April 17, 2025, to include a letter from Mr. Romanek as Exhibit 99.1, which was not previously included in their April 9, 2025, 8-K filing. This amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Why It Matters
This amendment clarifies previously filed information by adding a crucial letter from Mr. Romanek, potentially impacting understanding of officer and director changes.
Risk Assessment
Risk Level: low — The filing is an amendment to add an exhibit, not a material event itself.
Key Players & Entities
- THC Therapeutics, Inc. (company) — Filer
- Mr. Romanek (person) — Subject of letter included in amendment
- April 9, 2025 (date) — Date of original 8-K filing
- April 17, 2025 (date) — Date of 8-K/A filing
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to the Current Report on Form 8-K filed on April 9, 2025, to include a letter from Mr. Romanek as Exhibit 99.1.
What was missing from the original April 9 Form 8-K?
Prior to the filing of the April 9 Form 8-K, THC Therapeutics, Inc. had not received the letter from Mr. Romanek that is now included as Exhibit 99.1 in this amendment.
When was the original 8-K filing made?
The original 8-K filing was made on April 9, 2025.
What is the accession number for this filing?
The accession number for this 8-K/A filing is 0001477932-25-002821.
What items are covered by this 8-K/A filing?
This 8-K/A filing covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; and Financial Statements and Exhibits.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 17, 2025 by Mr. Romanek regarding THC Therapeutics, Inc..